Visualized clinical–radiomics model for predicting the efficacy of surufatinib in hepatic metastases of neuroendocrine neoplasms
The clinical-radiomics fusion model can effectively identify patients with HM-NENs sensitive to surufatinib therapy. The nomogram provided clinicians with a convenient and dependable tool for decision-making.
Authors
- Xiaoling Duan (ORCID: https://orcid.org/0009-0006-0883-0369)
- Miaomiao Feng (ORCID: https://orcid.org/0009-0000-4959-7539)
- Man Zhao (ORCID: https://orcid.org/0000-0002-9013-1498)
- Jiaojiao Hou
- Qi Wang (ORCID: https://orcid.org/0000-0002-5287-6050)
- Fei Yin (ORCID: https://orcid.org/0009-0004-7481-7598)
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/fonc.2025.1628054
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Government of Jiangxi Province
- Hebei Medical University
- Wu Jieping Medical Foundation